2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of a 30.75% …
CenTex CBD is closing their doors amidst uncertainty and political debate
The ongoing battle to ban THC in Texas led to their decision.
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ / ACCESS Newswire / August 5, 2025 / CBD Life Sciences Inc. (OTC:CBDL …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety …
Enhanced Efficacy: ART12.11 reversed stress-induced behavioral deficits and produced robust anti-depressant and anxiolytic-like effects. These benefits were superior to CBD alone, TMP alone, or a …
Learning to Reduce Inflammation by Using CBD
Inflammation is the body’s normal response to injuries and invaders (like germs). Designed to promote healing, chronic inflammation occurs when the body’s immune system fails to shut off. It can …
Charlotte’s Web Forms Scientific Advisory Board to Boost Medical Strategy
The latest announcement is out from Charlotte’s Web Holdings ( ($TSE:CWEB) ). Charlotte’s Web Holdings, a leader in hemp-derived CBD wellness, has …
Avicanna Expands Global Reach with First CBD Flower Export to Switzerland
Avicanna ( ($TSE:AVCN) ) has provided an update. Avicanna’s subsidiary, Santa Marta Golden Hemp SAS, has successfully completed its first export …
Why value investing has worked better outside the US
While value has outperformed growth in Europe over the past five years, Europe now represents less than half of equity market capitalization outside the US. Rather, value stocks in emerging markets …
CENTR Brands Corp. Closes $150,000 Private Placement to Bolster Financial Position
CENTR Brands ( ($TSE:CNTR) ) just unveiled an update. CENTR Brands Corp. has successfully closed a non-brokered private placement of unsecured …
Tilray Medical Study Finds Oral THC:CBD Extract Offers Faster, Higher Bioavailability
Tilray Brands Inc. (NASDAQ:TLRY) is one of the best penny stocks under $1 to buy now. On June 26, Tilray Brands, through its medical division, Tilray Medical, published a new scientific study on the …
InnoCan Pharma Stock: Nasdaq Listing Filing Signals Major Leap
InnoCan Pharma has officially filed registration documents with the SEC for a Nasdaq listing on July 23, 2025, marking a transformative moment for the Israeli-Canadian biotech company. The …
Cronos Group Inc. (CRON): A Bull Case Theory
This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion …
Recent Comments